SFA Therapeutics Alternatives & Competitors

12 companies similar to SFA Therapeutics — A New Paradigm in Drug Development

Biond Biologics Ltd

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...

43 Series C $32.00M

Israel

Biotechnology Health Care +1

MediMabBio

A biotechnology company that focuses on developing new therapeutic drugs targeting Oncolog...

15 Non Equity Assistance

Korea South

Biotechnology Health Care +1

Apexigen

Creating Transformative Immunotherapies for Patients with Cancer

11 Post-IPO Equity $175.80M

San Carlos, United States

Biopharma Biotechnology +2

ImmunoGenesis, Inc.

Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mech...

14 Venture round $28.00M

Houston, United States

Biotechnology Health Care +2

Track all SFA Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Tolerx, Inc.

9 Venture round $145.50M

Cambridge, United States

Biotechnology Health Care

HiFiBiO Therapeutics

HiFiBiO Therapeutics is a clinical stage biotherapeutics company mobilizing the human immu...

35 Series D $179.50M

Cambridge, United States

Biopharma Biotechnology +2

DBV Technologies

On a mission to advance epicutaneous immunotherapy using our innovative technology platfor...

187 Post-IPO Equity $239.80M

Chatillon, France

Biopharma Biotechnology +1

Compare

NexImmune, Inc.

NexImmune, Directing T cell function to restore natural immunity

32 Post-IPO Equity $87.44M

Gaithersburg, United Stat...

Biopharma Biotechnology +1

Checkmate Pharmaceuticals

Pioneering advanced immunotherapies to amplify cancer treatment options and improve patien...

11-50 Series C $170.00M

Biotechnology Health and Wellness +2

Atom Therapeutics

Atom Therapeutics Co., Ltd

4 Series D $678.08M

Suzhou, China

Biotechnology Health Care

IpiNovyx Bio

We are a drug platform focused on treating autoimmune and inflammatory diseases.

6 Seed $10.00M

United States

Biopharma Biotechnology +1

NextCure, Inc.

49 Post-IPO Equity $310.00M

Beltsville, United States

Biopharma Biotechnology +1

About SFA Therapeutics

SFA Therapeutics is a clinical stage start-up biotech company founded in 2016 with a focus on developing compounds discovered in the human microbiome. Their patented and proprietary platform aims to immuno-modulate inflammatory factors derived from the human gut microbiome. The technology, licensed from and supported b...

Business keywords

Biotech, Drug Development, Microbiome, Immunotherapy, Clinical Stage, Patented Technology, Inflammatory Disease, Autoimmune Disease, Cancer Treatment, Liver Disease, Temple University, Biopharmaceutical, Metabolites As Drugs, Immuno-modulation, Startup

Frequently Asked Questions

Companies similar to SFA Therapeutics include Biond Biologics Ltd, MediMabBio, Apexigen, ImmunoGenesis, Inc., Tolerx, Inc.. They work in Biotechnology and Health Care and share SFA Therapeutics's focus on immunotherapy, cancer treatment and drug development.

Bounce Watch lists 12 companies that share SFA Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches SFA Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

SFA Therapeutics Profile Biond Biologics Ltd Alternatives MediMabBio Alternatives Apexigen Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at SFA Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 25 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.